Single User License
INR 96975
Site License
INR 193950
Corporate User License
INR 290925

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Acucela Inc.-Product Pipeline Review-2015

Acucela Inc.-Product Pipeline Review-2015

  • Products Id :- GMDHC06847CDB
  • |
  • Pages: 27
  • |
  • March 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Acucela Inc.-Product Pipeline Review-2015


Global Markets Direct's, 'Acucela Inc.-Product Pipeline Review-2015', provides an overview of the Acucela Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Acucela Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Acucela Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Acucela Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Acucela Inc.'s pipeline products

Reasons To Buy

Evaluate Acucela Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Acucela Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Acucela Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Acucela Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Acucela Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Acucela Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Acucela Inc. Snapshot 4

Acucela Inc. Overview 4

Key Information 4

Key Facts 4

Acucela Inc.-Research and Development Overview 5

Key Therapeutic Areas 5

Acucela Inc.-Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products-Monotherapy 8

Pipeline Products-Partnered Products 9

Partnered Products/Combination Treatment Modalities 10

Acucela Inc.-Pipeline Products Glance 11

Acucela Inc.-Late Stage Pipeline Products 11

Phase III Products/Combination Treatment Modalities 11

Acucela Inc.-Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Acucela Inc.-Drug Profiles 13

emixustat hydrochloride 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

Small Molecule for Retinitis Pigmentosa 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

Small Molecule for Retinopathy of Prematurity 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Small Molecule for Stargardt Disease 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Acucela Inc.-Pipeline Analysis 18

Acucela Inc.-Pipeline Products by Target 18

Acucela Inc.-Pipeline Products by Route of Administration 19

Acucela Inc.-Pipeline Products by Molecule Type 20

Acucela Inc.-Pipeline Products by Mechanism of Action 21

Acucela Inc.-Recent Pipeline Updates 22

Acucela Inc.-Dormant Projects 24

Acucela Inc.-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Appendix 26

Methodology 26

Coverage 26

Secondary Research 26

Primary Research 26

Expert Panel Validation 26

Contact Us 26

Disclaimer 27

List of Tables

Acucela Inc., Key Information 4

Acucela Inc., Key Facts 4

Acucela Inc.-Pipeline by Indication, 2015 6

Acucela Inc.-Pipeline by Stage of Development, 2015 7

Acucela Inc.-Monotherapy Products in Pipeline, 2015 8

Acucela Inc.-Partnered Products in Pipeline, 2015 9

Acucela Inc.-Partnered Products/ Combination Treatment Modalities, 2015 10

Acucela Inc.-Phase III, 2015 11

Acucela Inc.-Preclinical, 2015 12

Acucela Inc.-Pipeline by Target, 2015 18

Acucela Inc.-Pipeline by Route of Administration, 2015 19

Acucela Inc.-Pipeline by Molecule Type, 2015 20

Acucela Inc.-Pipeline Products by Mechanism of Action, 2015 21

Acucela Inc.-Recent Pipeline Updates, 2015 22

Acucela Inc.-Dormant Developmental Projects,2015 24

Acucela Inc., Other Locations 25

List of Figures

Acucela Inc.-Pipeline by Top 10 Indication, 2015 6

Acucela Inc.-Pipeline by Stage of Development, 2015 7

Acucela Inc.-Monotherapy Products in Pipeline, 2015 8

Acucela Inc.-Partnered Products in Pipeline, 2015 9

Acucela Inc.-Pipeline by Top 10 Target, 2015 18

Acucela Inc.-Pipeline by Top 10 Route of Administration, 2015 19

Acucela Inc.-Pipeline by Top 10 Molecule Type, 2015 20

Acucela Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Acucela Inc.; Acucela Inc. - Key Therapeutics; Acucela Inc. - Pipeline Overview and Promising Molecules; Acucela Inc. - News; Acucela Inc. - Latest Updates; Acucela Inc. - Pipeline; Acucela Inc. - Discontinued/Dormant Projects

Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]